TickerGuard
Buy Day today: Neutral (51) Mixed market breadth · no major macro event
TECH

Bio-Techne Corp

Healthcare · Biotechnology

72.40$ -0.1% vs. previous close Closing price · As of: Sep 18, 2026

Statements

Balance Sheet

Bio-Techne Corp (TECH) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (Q2 26), "Total Assets" came in at 2,587 million USD. Tick rows to compare them in a chart.

Income Statement Balance Sheet Cash Flow Ratios
Annual Quarterly
Amounts Change % Common size %
Last 12 Full history
Download as CSV

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TECH
Line item Q3 23 Q4 23 Q1 24 Q2 24 Q3 24 Q4 24 Q1 25 Q2 25 Q3 25 Q4 25 Q1 26 Q2 26
2,755 2,731 2,721 2,704 2,736 2,670 2,644 2,558 2,526 2,523 2,551 2,587
591 591 611 617 649 635 627 608 610 637 688 744
149 130 140 152 188 178 141 162 145 173 210 265
149 136 145 153 188 178 141 162 145 173 210 265
205 207 228 241 224 218 237 207 184 185 218 217
186 181 179 180 185 188 191 189 203 205 201 196
969 980 971 973 983 965 969 981 979 981 978 975
579 551 526 507 486 461 444 366 350 335 319 303
758 767 707 635 597 592 626 639 560 512 465 479
128 135 150 159 142 161 169 176 145 140 153 164
12 13 13 13 13 14 14 14 14 14 14 15
28 32 29 38 32 33 32 25 30 26 23 105
440 447 389 319 300 300 330 346 300 260 200 200
1,998 1,964 2,014 2,069 2,139 2,078 2,018 1,919 1,966 2,011 2,085 2,108
1,328 1,261 1,298 1,325 1,341 1,287 1,196 1,066 1,083 1,107 1,145 1,144
162 160 160 161 161 161 159 156 156 157 157 157

Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?